169 related articles for article (PubMed ID: 35159184)
1. The Fairy Chemical Imidazole-4-carboxamide Inhibits the Expression of Axl, PD-L1, and PD-L2 and Improves Response to Cisplatin in Melanoma.
Inoue C; Yasuma T; D'Alessandro-Gabazza CN; Toda M; Fridman D'Alessandro V; Inoue R; Fujimoto H; Kobori H; Tharavecharak S; Takeshita A; Nishihama K; Okano Y; Wu J; Kobayashi T; Yano Y; Kawagishi H; Gabazza EC
Cells; 2022 Jan; 11(3):. PubMed ID: 35159184
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of the Fairy Chemicals, 2-Azahypoxanthine and Imidazole-4-carboxamide, in the Fairy Ring-Forming Fungus
Ito A; Choi JH; Takemura H; Kotajima M; Wu J; Tokuyama S; Hirai H; Asakawa T; Ouchi H; Inai M; Kan T; Kawagishi H
J Nat Prod; 2020 Aug; 83(8):2469-2476. PubMed ID: 32786881
[TBL] [Abstract][Full Text] [Related]
3. A Fairy Chemical, Imidazole-4-carboxamide, is Produced on a Novel Purine Metabolic Pathway in Rice.
Takemura H; Choi JH; Matsuzaki N; Taniguchi Y; Wu J; Hirai H; Motohashi R; Asakawa T; Ikeuchi K; Inai M; Kan T; Kawagishi H
Sci Rep; 2019 Jul; 9(1):9899. PubMed ID: 31289299
[TBL] [Abstract][Full Text] [Related]
4. Fairy chemicals - a candidate for a new family of plant hormones and possibility of practical use in agriculture.
Kawagishi H
Biosci Biotechnol Biochem; 2018 May; 82(5):752-758. PubMed ID: 29513130
[TBL] [Abstract][Full Text] [Related]
5. Are fairy chemicals a new family of plant hormones?
Kawagishi H
Proc Jpn Acad Ser B Phys Biol Sci; 2019; 95(1):29-38. PubMed ID: 30643094
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin Augments Antitumor T-Cell Responses Leading to a Potent Therapeutic Effect in Combination With PD-L1 Blockade.
Wakita D; Iwai T; Harada S; Suzuki M; Yamamoto K; Sugimoto M
Anticancer Res; 2019 Apr; 39(4):1749-1760. PubMed ID: 30952714
[TBL] [Abstract][Full Text] [Related]
7. Plant-growth regulator, imidazole-4-carboxamide, produced by the fairy ring forming fungus Lepista sordida.
Choi JH; Abe N; Tanaka H; Fushimi K; Nishina Y; Morita A; Kiriiwa Y; Motohashi R; Hashizume D; Koshino H; Kawagishi H
J Agric Food Chem; 2010 Sep; 58(18):9956-9. PubMed ID: 20734987
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PAI-1 Blocks PD-L1 Endocytosis and Improves the Response of Melanoma Cells to Immune Checkpoint Blockade.
Tseng YJ; Lee CH; Chen WY; Yang JL; Tzeng HT
J Invest Dermatol; 2021 Nov; 141(11):2690-2698.e6. PubMed ID: 34000287
[TBL] [Abstract][Full Text] [Related]
9.
Ouchi H; Namiki T; Iwamoto K; Matsuzaki N; Inai M; Kotajima M; Wu J; Choi JH; Kimura Y; Hirai H; Xie X; Kawagishi H; Kan T
J Nat Prod; 2021 Feb; 84(2):453-458. PubMed ID: 33480692
[TBL] [Abstract][Full Text] [Related]
10. The biosynthetic pathway of 2-azahypoxanthine in fairy-ring forming fungus.
Suzuki T; Yamamoto N; Choi JH; Takano T; Sasaki Y; Terashima Y; Ito A; Dohra H; Hirai H; Nakamura Y; Yano K; Kawagishi H
Sci Rep; 2016 Dec; 6():39087. PubMed ID: 27991529
[TBL] [Abstract][Full Text] [Related]
11. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Mahoney KM; Freeman GJ; McDermott DF
Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
[TBL] [Abstract][Full Text] [Related]
12. Role of hypoxanthine-guanine phosphoribosyltransferase in the metabolism of fairy chemicals in rice.
Takemura H; Choi JH; Fushimi K; Narikawa R; Wu J; Kondo M; Nelson DC; Suzuki T; Ouchi H; Inai M; Hirai H; Kawagishi H
Org Biomol Chem; 2023 Mar; 21(12):2556-2561. PubMed ID: 36880328
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune.
Jiang Z; Yang Y; Yang Y; Zhang Y; Yue Z; Pan Z; Ren X
Biomed Pharmacother; 2017 Dec; 96():378-383. PubMed ID: 29031195
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy.
Zhang P; Ma Y; Lv C; Huang M; Li M; Dong B; Liu X; An G; Zhang W; Zhang J; Zhang L; Zhang S; Yang Y
Cancer Sci; 2016 Nov; 107(11):1563-1571. PubMed ID: 27581532
[TBL] [Abstract][Full Text] [Related]
15. The Mixture of Natural Products SH003 Exerts Anti-Melanoma Effects through the Modulation of PD-L1 in B16F10 Cells.
Han NR; Park HJ; Ko SG; Moon PD
Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375695
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles.
Grabosch S; Bulatovic M; Zeng F; Ma T; Zhang L; Ross M; Brozick J; Fang Y; Tseng G; Kim E; Gambotto A; Elishaev E; P Edwards R; Vlad AM
Oncogene; 2019 Mar; 38(13):2380-2393. PubMed ID: 30518877
[TBL] [Abstract][Full Text] [Related]
17. A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.
Wang Y; Gu T; Tian X; Li W; Zhao R; Yang W; Gao Q; Li T; Shim JH; Zhang C; Liu K; Lee MH
Front Immunol; 2021; 12():654463. PubMed ID: 34054817
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer.
Fournel L; Wu Z; Stadler N; Damotte D; Lococo F; Boulle G; Ségal-Bendirdjian E; Bobbio A; Icard P; Trédaniel J; Alifano M; Forgez P
Cancer Lett; 2019 Nov; 464():5-14. PubMed ID: 31404614
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 and PD-L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma.
Okadome K; Baba Y; Yasuda-Yoshihara N; Nomoto D; Yagi T; Toihata T; Ogawa K; Sawayama H; Ishimoto T; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Komohara Y; Baba H
Cancer Sci; 2022 Feb; 113(2):399-410. PubMed ID: 34773342
[TBL] [Abstract][Full Text] [Related]
20. Ribosides and Ribotide of a Fairy Chemical, Imidazole-4-carboxamide, as Its Metabolites in Rice.
Choi JH; Matsuzaki N; Wu J; Kotajima M; Hirai H; Kondo M; Asakawa T; Inai M; Ouchi H; Kan T; Kawagishi H
Org Lett; 2019 Oct; 21(19):7841-7845. PubMed ID: 31518147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
